Applicant, as named in the Orange Book

Mallinckrodt Ireland

Next listed expiry: Inomax on 30 Jun 2029. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Inomax NDA 020845 · 2 strengths nitric oxide	nitric oxide	30 Jun 2029 patent	patent
Terlivaz NDA 022231 terlipressin acetate	terlipressin acetate	5 Apr 2037 patent, carve-out possible	patent, carve-out possible
Acthar Gel NDA 008372 corticotropin	corticotropin	18 Jul 2041 patent, carve-out possible	patent, carve-out possible
Acthar Gel (Autoinjector) NDA 008372 · 2 strengths corticotropin	corticotropin	18 Jul 2041 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.